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CASE PRESENTATION
A 23-year-old man presented to our institution in May
2002 at the recommendation of his primary nephrologist
in Puerto Rico for a second opinion regarding chronic
glomerulonephritis. He had a history of a tectal pilocytic
astrocytoma, which was diagnosed in 1992. The tumor
was complicated by obstructive hydrocephalus that
required ventriculoatrial (VA) shunt placement. He
underwent partial tumor resection followed by radiation
therapy and had required multiple revisions of his shunt,
most recently in 1997. A magnetic resonance imaging of
the brain obtained prior to presentation at our institution
revealed prominent nodularity in the tectal region
suspicious for residual tumor. In addition, there were
extensive post-surgical and post-radiation changes in
the medial aspect of the left occipital lobe.
In 1999, he developed mild renal insufficiency with
nephrotic-range proteinuria and microhematuria. A
serologic work-up, the details of which were not available
to us at the time of his presentation, was reportedly
negative. Renal biopsy was performed in Puerto Rico, but
only four glomeruli were sampled. Two out of the four
glomeruli were reportedly sclerotic, whereas the other
two demonstrated mesangial proliferation. The patient
received a course of steroids for mesangio-proliferative
glomerulonephritis of unclear etiology. After a brief period
of initial response, he had several relapses in proteinuria
and was kept on chronic prednisone for presumed
idiopathic steroid-dependent glomerulonephritis.
At the time of presentation at our institution, the
patient’s medications included prednisone 20mg once
daily, furosemide 20mg twice daily, metolazone 5mg
once daily, and valsartan 160mg once daily. The patient
denied smoking, alcohol, or recreational drug use.
He also denied risk factors for HIV infection. There was no
family history of renal disease.
On physical examination, he was afebrile with a pulse
of 68 bpm and a blood pressure of 130/82mmHg. He was
cushingoid and had severe acne on the face and anterior
chest wall. The shunt was palpable under the skin of the
neck, without evidence of erythema or tenderness. The
pupils were equal and reactive to light, but the eye
movements were notable for right exotropia. In addition,
the patient had bilateral nystagmus and his hearing was
decreased on the left side. The heart, lung, and abdominal
examinations were unremarkable. The skin exam
demonstrated multiple striae, predominantly in the
abdominal area. Severe pitting edema of both legs was
present. Examination of the joints and lymph nodes was
unremarkable. Coordination, gait, and detailed peripheral
sensory and motor exams were also within normal limits.
Initial laboratory results are summarized in Table 1.
Most notably, moderate renal insufficiency,
hypoalbuminemia, leukocytosis, and anemia were
present. Serum creatinine was 1.5mg per 100ml
(reference 0.5–0.9), a spot urine protein to creatinine ratio
was 3.2, and urine microscopy revealed 20 RBCs per
high-power field. Hepatic enzymes and thyroid function
testing were within normal limits. Additional work-up
revealed an elevated erythrocyte sedimentation rate of
65mm/hr (normal 0–15), low serum complement C3 of
50mg per 100ml (normal 83–177), and low-normal C4 of
19mg per 100ml (normal 16–47). Other serologic tests,
including antibodies to hepatitis B and C, antinuclear
antibodies, rheumatoid factor, cryoglobulins, and
anti-streptolysin-O were all negative. Renal ultrasound
showed normal sized kidneys with no hydronephrosis
and normal echotexture. The renal veins and arteries
were patent on Doppler examination. Chest X-ray
revealed small bilateral pleural effusions. Radiographs
of a shunt series verified correct shunt position, with
the cephalad tip in the cranial fossa and the distal tip
projecting over the expected location of the right
atrium of the heart.
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Upon review of the original kidney biopsy slides from
Puerto Rico, it was felt that the sampling of only four
glomeruli with predominant sclerosing features was
inadequate for rendering a definitive diagnosis and
guiding subsequent management. In the light of the
patient’s ongoing renal insufficiency, proteinuria,
hematuria, and hypocomplementemia, a repeat kidney
biopsy was performed.
BIOPSY FINDINGS
The renal biopsy contained 36 glomeruli, 29 of which were
globally sclerotic. Several of the obsolescent glomeruli
displayed circumferential subcapsular fibrous proliferation
with disruption of Bowman’s capsule, suggesting old fibrous
crescents. The remaining seven glomeruli appeared enlarged
with accentuated lobularity (Figure 1a). There was severe
diffuse and global mesangial expansion by increased mesan-
gial cell number and matrix associated with membranopro-
liferative features in the form of circumferential mesangial
interposition and narrow duplication of glomerular basement
membranes (Figure 1b). Many glomeruli contained infiltrating
neutrophils as well as occasional eosinophils. Two glomeruli
contained small segmental crescents, one of which was cellular
and the other fibrocellular. Approximately 30–40% of the
cortex displayed patchy tubular atrophy and interstitial fibrosis
accompanied by a moderate focal interstitial infiltrate of
lymphocytes, monocytes, plasma cells, and occasional neu-
trophils. There were focal red blood cell casts. Some proximal
tubular cells contained intracytoplasmic protein and lipid
resorption droplets. There was mild to moderate arterio-
and arteriolosclerosis. No arteritis was identified. The single
non-sclerotic glomerulus sampled for immunofluorescence
revealed semilinear to granular glomerular capillary wall
positivity for IgG (1þ ), IgM (1þ ), C3 (2þ ), C1 (1þ ),
kappa, and lambda (both trace) in a subendothelial distribu-
tion with weaker mesangial positivity (Figure 1c).
On electron microscopy, glomerular capillary lumina were
narrowed or occluded by marked mesangial hypercellularity
and increased matrix accompanied by mesangial interposi-
tion and duplication of glomerular basement membranes.
Some expanded mesangial regions were more sclerotic, with
increased matrix and nodularity. Many lobules contained
infiltrating monocytes or neutrophils, sometimes associated
with endothelial swelling and hypercellularity. There were
numerous small mesangial and subendothelial electron-dense
deposits with a granular texture, lacking organized sub-
structure (Figure 1d). Foot process effacement involved
approximately 90% of the glomerular capillary surface area.
DIFFERENTIAL DIAGNOSIS
Three distinct categories of disease may be associated with
a membranoproliferative pattern of glomerular injury on
light microscopy. These include immune complex-mediated
diseases, thrombotic microangiopathies, and paraprotein
deposition diseases.1 In this case, the presence of granular
mesangial and subendothelial electron-dense deposits seen
on electron microscopy, combined with the presence of
polyclonal immunoglobulins and complement components
seen on immunofluorescence, point to an immune-complex
mediated process. The differential diagnosis includes idio-
pathic versus secondary forms of membranoproliferative
glomerulonephritis. A listing of the differential diagnosis of
immune complex-mediated membranoproliferative glomer-
ulonephritis is provided in Table 2. Apart from his renal
disease, this patient had no other clinical manifestations of a
systemic autoimmune process, and with the exception of
hypocomplementemia, rheumatologic serologies were un-
remarkable. Additional testing for viral, bacterial, and
parasitic infections would be needed to exclude infectious
causes of secondary membranoproliferative glomerulo-
nephritis. In this patient with a longstanding VA shunt,
Table 1 | Laboratory results
Test
Initial
presentation
(May 2002)
2 weeks after
shunt removal
(August 2002)
1 year after shunt
removal (September
2003)
4 years after shunt
removal (April-June
2006)
Reference
range
Blood urea nitrogen (mg per 100ml) 64 27 19 11 7–20
Creatinine (mg per 100ml) 1.5 1.3 1.3 1.0 0.5–0.9
Albumin (g per 100ml) 3.0 2.9 — 4.6 4.0–5.0
WBC (109/l) 13.4 13.4 8.6 9.7 3.5–9.0
Hemoglobin (g per 100ml) 8.2 7.8 12.1 13.5 12.0–15.0
Platelet 109/l) 260 354 251 294 165–415
C3 (mg per 100ml) 50 72 72 82 83–177
C4 (mg per 100ml) 19 28 28 35 16–47
CH50 (%) 10 48 83 159 50–150
Urine protein (mg per 100ml) 252 — 19 6 0–10
Urine creatinine (mg per 100ml) 78 — 138 94 -
Urine dipstick 3+ Albumin 3+ Albumin Neg albumin Neg albumin Neg albumin
3+ Blood 3+ Blood 1+ Blood Neg blood Neg blood
Urine microscopy 6 WBC/hpf 2 WBC/hpf 2 WBC/hpf 0 WBC/hpf 0–3 WBC/hpf
49 RBC/hpf 20 RBC/hpf 12 RBC/hpf 0 RBC/hpf 0–3 RBC/hpf
hpf, high-power field; Neg, negative.
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secondary membranoproliferative glomerulonephritis due to
subacute infection of the shunt leading to immune complex-
mediated glomerular injury, ‘shunt nephritis’, was a strong
etiologic consideration.
CLINICAL FOLLOW-UP
Outpatient blood cultures were obtained and grew Propio-
nibacterium acnes. The patient was admitted to the hospital.
Cerebrospinal fluid (CSF) cultures were obtained from the
VA shunt and they also grew P. acnes. The patient was started
on empiric broad-spectrum antibiotics, including intrave-
nous cefotaxime, vancomycin, and ampicillin. In spite of
antibiotic therapy, CSF cultures obtained from the shunt
remained positive for six consecutive days. He was taken to
the operating room for removal of the shunt and an
endoscopic frontal third ventriculostomy. After final identi-
fication and sensitivity testing of the P. acnes isolate, he was
kept on cefotaxime monotherapy for a total of 4 weeks of
antibiotic treatment, the latter portion of which he received
at home via a peripherally inserted central catheter. The
follow-up trends in creatinine, proteinuria, and complement
components are summarized in Figure 2. Creatinine level fell
from a peak of 1.7mg per 100ml prior to shunt removal and
antibiotic therapy, down to 1.3mg per 100ml within two
weeks after the surgery. Valsartan was continued at 160mg
daily and prednisone was initially continued at 20mg daily.
The patient’s proteinuria declined, and within 12 months the
urine protein to creatinine ratio was down to 0.1. Over this
a
c
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Figure 1 |Renal biopsy findings. (a) A representative glomerulus appears hypercellular and hyperlobulated due to global mesangial and
endocapillary proliferation, including focal infiltrating neutrophils (hematoxylin and eosin,  400 original magnification). (b) The mesangial
areas display increased cells and matrix, with a nodular appearance. There are many double contours of the glomerular basement membranes
as well as focal neutrophil infiltration (Periodic acid–Schiff,  400 original magnification). (c) By immunofluorescence, there is 2þ granular to
semilinear staining for C3 outlining the glomerular capillary walls in a subendothelial distribution. Weaker, less abundant granular positivity is
also noted in the mesangial areas (immunofluorescence, anti-C3,  500 original magnification). (d) The mesangial areas are expanded by
nodular mesangial sclerosis (arrowhead). Subendothelial electron-dense deposits are noted (arrow). There is extensive effacement of foot
processes (electron micrograph,  2000 original magnification).
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time period, a slow steroid taper was initiated and the
prednisone, along with valsartan, were finally discontinued in
June 2004, approximately 24 months after shunt removal and
antibiotic therapy. In July 2004 the patient developed
headache, ataxia, and worsening hearing loss. MRI of the
brain demonstrated aqueductal outflow obstruction. Tumor
de-bulking procedure was performed and a ventriculoper-
itoneal shunt was placed. One year later, the patient was
noted to develop recurrent low-grade proteinuria (urine
protein to creatinine ratio 0.9). Serum creatinine during this
time was 1.1mg per 100ml; there was no recurrent
microhematuria and no evidence of new shunt infection.
The proteinuria decreased following re-initiation of low-dose
valsartan. Five years after VA shunt removal and antibiotic
therapy, the patient’s creatinine is 1mg per 100ml and spot
urine protein to creatinine ratio is 0.3.
FINAL DIAGNOSIS
Membranoproliferative and sclerosing glomerulonephritis
with exudative features and focal crescent formation due to
P. acnes-induced shunt nephritis.
DISCUSSION
Since the initial description of immune complex glomerulo-
nephritis associated with infection of a VA shunt in 1965,2
over 160 case reports have appeared in the literature
(reviewed by Haffner et al.3 and Arze et al.4). Common
clinical features in patients with shunt nephritis include
renal insufficiency of variable severity, hematuria, proteinuria
(usually in the subnephrotic range), hypertension, and
anemia. Serum complement levels generally are depressed
and cryoglobulins as well as antinuclear antibodies may be
detected. Although low-grade fevers may be present, not all
patients demonstrate typical signs and symptoms of active
infection. As a result, a substantial delay from the onset of
the initial renal manifestations to the definitive diagnosis
(including demonstration of occult shunt infection) may be
present. Moreover, the onset of hematuria, proteinuria, and
renal insufficiency may vary from several weeks to several
years after the patient’s initial shunt surgery or latest shunt
revision. Most but not all patients have positive cultures
of either the blood, CSF, or both. Renal biopsy is helpful in
Table 2 | Differential diagnosis for MPGN pattern with
immune-complex deposition
Disease Comments
Primary MPGN disease
MPGN type I
(idiopathic)
-Discrete immune complex deposition in the
mesangium and subendothelial space with secondary
activation of the classical complement pathway.
Nephritic or nephrotic presentation. Diagnosis of
exclusion. Unknown cause
MPGN type II
(dense-deposit
disease)
-Continuous, dense, ribbon-like C3-rich deposits
along GBM, TBM, and Bowman’s capsule caused by an
overactive alternative complement pathway. Serum
C4 is normal, but C3 is markedly depressed.
Predominantly nephritic presentation. Caused by C3
nephritic factor (antibody stabilizing alternative C3
convertase) or loss of factor H function (genetic or
acquired)
MPGN type III
Burkholder
variant
-Numerous subepithelial and subendothelial
deposits. Presentation and course similar to MPGN
type I
Strife and
Anders
variant
-Predominantly intramembranous deposits and
prominent disruptions in the GBM. Depression of C3
is common
Secondary MPGN pattern with immune-complex depositsa
Chronic infections
Viral: HCV and cryoglobulinemia type II (most common), HBV, HIV
Bacterial: endocarditis, visceral abscess, osteomyelitis, shunt
infections
Other: malaria, schistosomiasis, leprosy, mycoplasma
Autoimmune and inflammatory
SLE, RA, Sjogren’s
Sarcoidosis
Neoplastic
Hematologic: CLL and NHL
Solid tumors: melanoma and carcinomas
Genetic
Complement deficiencies
Partial lipodystrophies
a-1-antitrypsin deficiency
CLL, chronic lymphocytic leukemia; GBM, glomerular basement membrane; HBV,
hepatitis B virus; HCV, hepatitis C virus; MPGN, membranoproliferative glomer-
ulonephritis; NHL, non-Hodgkin’s lymphoma; RA, rheumatoid arthritis; SLE, systemic
lupus erythematosus; TBM, tubular basement membrane.
aFor a complete referenced review of conditions associated with a secondary MPGN
pattern, please refer to Rennke, 1995.
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Figure 2 |Trend in serum creatinine (red), estimated proteinuria
(blue), and CH50 (green) over 4 years of follow-up.
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establishing a causal relationship between the patient’s renal
manifestations and shunt infection. Typical findings on renal
biopsy include a membranoproliferative pattern of glome-
rular injury seen on light microscopy, with immunofluores-
cence demonstrating granular subendothelial and mesangial
deposits containing polyclonal immunoglobulins (IgM and
IgG) and complement (mainly C3). The mechanism of renal
injury probably involves persistent antigenemia derived from
an infectious agent, which stimulates immune complex
formation. It is unclear whether the immune complexes
are formed in the circulation and then passively deposited in
the glomeruli, or if they form in situ after foreign antigens
are first trapped within the glomerular filtration barrier.
The presence of immune complexes induces classical pathway
complement activation, which in turn mediates direct injury
to glomerular cells (via the C5–9 complex) and generates
chemotactic peptides (C3a, C5a) that perpetuate local
inflammation.1
MICROBIOLOGY OF SHUNT NEPHRITIS
The most commonly reported organism causing CNS shunt
infection with nephritis is Staphylococcus epidermidis,3
accounting for 70% of isolates described in the cases reviewed
by Arze et al.4 P. acnes is the next most commonly reported
organism. The first reported examples of P. acnes shunt
infection were by Beeler et al. in 1976.5 Of the three cases
summarized by their report, one had a concomitant
immune-complex glomerulonephritis, an entity not pre-
viously associated with anaerobic organisms and certainly
not expected with P. acnes, which at the time was generally
considered to be a non-virulent commensal skin organism.
Since then, of the approximately 160 reported cases of shunt
nephritis with microbiologic data (including those reported
by Arze in 1983,4 Haffner in 1998,3 and the additional
17 cases reported in the last 10 years), at least 10 cases appear
to have been mediated by P. acnes. However, the true
incidence of P. acnes shunt infection is probably higher than
reported, due to the organism’s lengthy incubation period
and poor growth on certain culture media.6
Propionibacterium species are Gram-positive anaerobic
bacilli, typically found among normal skin flora, as well as in
the oral cavity, colon, conjunctiva, and external ear canal. In
the skin, P. acnes clusters in moist environments, such as the
axilla or groin areas, preferentially around hair follicles and
sebaceous glands. The organism is slow growing and capable
of surviving up to 8 months under anaerobic conditions. In
addition to shunt infections, several other serious complica-
tions of P. acnes have been reported over the last three
decades (Table 3). In general, invasive P. acnes infections tend
to occur in the setting of antecedent trauma such as surgery,
or in the presence of prosthetic devices. P. acnes has recently
been shown to have the ability to form a biofilm (a matrix of
extracellular polymeric substances embedding and protecting
microorganisms and enabling their communication through
biochemical signals).22,23 Biofilm formation facilitates infec-
tions of implanted materials and explains why such infections
are difficult to treat without surgical removal of the device,
despite the organism’s susceptibility to common antibiotics.
Recent studies have helped define other virulence factors
specific to P. acnes. This search has been greatly facilitated
by the recent publication of the complete sequence of the
P. acnes genome.24 Detailed analysis of the coding regions has
revealed numerous putative virulence genes. These genes may
be subdivided into two groups: those coding for proteins
involved in tissue invasion and those that modulate the host’s
inflammatory response. The first group involves enzymes
found in a variety of other pathogenic microorganisms25 as
well as several genes potentially involved in biofilm forma-
tion.22 The second group of genes includes sequences
of putative antigenic proteins, which are either present on
the microorganism’s surface or secreted into the extracellular
space. Members of this group are likely responsible for some
of the inflammatory conditions associated with P. acnes
infection, such as acne vulgaris, nephritis and possibly,
sarcoidosis (see Table 3). In contrast to the well-established
link between P. acnes and acne vulgaris and shunt nephritis,
an association with sarcoidosis remains controversial. It
was first suggested by Eishi and co-workers16 who detected
P. acnes DNA in mediastinal lymph nodes of patients with
pulmonary disease. While some investigators suggest that this
finding may be non-specific, as P. acnes has been found
Table 3 | Conditions associated with Propionibacterium acne
Associated conditions Comments
Infectious
Osteomyelitis After lumbar puncture7
Discitis After spine surgery8
Endocarditis After prosthetic valve replacement,9
annuloplasty,10 or pacemaker insertion11
Joint infections After orthopedic surgery12 or prosthetic
joint13
CNS infections After craniotomy or CNS shunt placement
(see text)
Endophthalmitis After eye surgery14
Inflammatory
Acne vulgaris P. acne is thought to colonize an anaerobic
environment of obstructed sebaceous
glands and contribute to the inflammatory
phase of acne vulgaris
Nephritis Immune-complex-mediated MPGN
pattern; CNS shunt (see text) and
endocarditis-associated15
Sarcoidosis P. acne DNA has been detected in
mediastinal lymph nodes16,17 and in BAL
cells18 of patients with pulmonary
sarcoidosis, as well as in kidney tissue of a
patient with renal sarcoidosis19
SAPHO (synovitis, acne,
pustulosis, hyperostosis,
osteitis)
Rare inflammatory arthro-osteitis of the
anterior chest wall associated with various
skin conditions, including palmoplantar
pustulosis, severe acnes, and pustular
psoriasis. There is some evidence that P.
acne infection may be involved in some
cases20,21
MPGN, membranoproliferative glomerulonephritis.
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in mediastinal lymph nodes of many subjects without
sarcoidosis,26 other studies support this intriguing asso-
ciation.17,18 Interestingly, the membranoproliferative pattern
of renal injury has been observed in patients with pulmonary
sarcoidosis.27–29 In addition, P. acnes DNA has been detected
by in situ hybridization in a kidney biopsy specimen of a
patient with renal sarcoidosis and glomerulonephritis.19
PROGNOSIS AND TREATMENT OF SHUNT NEPHRITIS
The finding of otherwise unexplained hematuria or proteinur-
ia, with even mild renal insufficiency in a patient with a VA
shunt should prompt an aggressive diagnostic approach to
exclude subacute shunt infection, even in patients without
fever or leukocytosis. P. acnes should always be considered as a
potential causative pathogen and anaerobic CSF and blood
cultures should be performed in all such cases. The prognosis
for stabilization and improvement in renal function and
proteinuria tends to be excellent, even in patients with renal
insufficiency at the time of diagnosis, provided the infected
shunt is removed in a timely manner and an appropriate
course of antibiotics is initiated. In the extensive case series
reported by Haffner et al.3 (82 cases), the longest reported
follow-up period was 22 years, with the patient at that time
demonstrating a normal serum creatinine of 0.7mg per 100ml
and no urinary abnormalities, in spite of renal insufficiency at
the time of diagnosis (creatinine 1.1 in a 5-year-old girl) and
50% of glomeruli demonstrating cellular crescents on biopsy.
In the earlier case review reported by Arze et al.4 (70 cases),
greater than 50% of patients were classified as experiencing
‘complete recovery’ of renal function after appropriate surgical
and antibiotic treatment, although the fact that these were
individual case reports brought together for the purposes of a
literature review makes it impossible to establish a standard
definition of what the authors refer to as ‘recovery’.
The vast majority of reported cases of shunt nephritis
have occurred in the setting of an existing VA rather than
ventriculoperitoneal shunt. Therefore, patients such as ours
who, after removal of the infected VA shunt, continue to
require CSF drainage due to symptomatic obstruction,
generally go on to have subsequent ventriculoperitoneal
rather than VA shunt replacement. Delayed removal or lack
of removal of the infected shunt, even if appropriate
antibiotics are administered, may be associated with
progressive renal failure leading to ESRD.3
Few, if any, data exist with which to make evidence-based
decisions regarding concomitant use of corticosteroid treat-
ment. Although the potential benefit of corticosteroids in
terms of reducing glomerular inflammation may seem
intuitive, clinicians may understandably be reluctant to
initiate immunosuppressive treatment in the setting of
documented CNS infection. Depending on the degree of
renal insufficiency at the time of diagnosis and the
relative severity of the acute (potentially reversible) inflam-
matory changes noted on biopsy, we feel that once the
shunt is removed and appropriate antibiotics are initiated, a
course of steroid treatment may be beneficial in helping to
reduce glomerular inflammation and thereby stabilize renal
function. As with all other forms of glomerular disease,
adequate blood pressure control and proteinuria reduction
should be attempted with judicious use of angiotensin-
converting enzyme inhibitors and/or angiotensin receptor
blockers.
SUMMARY
This case illustrates in a striking manner the potential renal
complications associated with chronic, unrecognized VA
shunt infection. The diagnosis of shunt nephritis is challen-
ging and, as exemplified by this case, may be overlooked for
several years, resulting in significant morbidity in the form of
ongoing renal injury with proteinuria and renal failure. The
finding of hematuria, proteinuria and even mild renal
insufficiency in a patient with a VA shunt should prompt
an aggressive microbiologic diagnostic evaluation to exclude
subacute infection. Renal biopsy should be considered to
document the pathognomonic membranoproliferative lesion
and to assess the relative degrees of acute versus chronic
injury. Further, this case highlights the critical importance of
excluding secondary forms of disease in any patient with a
nephritic presentation and biopsy findings demonstrating
membranoproliferative features, as identification and treat-
ment of the underlying condition may lead to remission of
proteinuria and normalization of renal excretory function,
even in patients with a baseline biopsy finding of significant
sclerosis alongside ongoing active inflammation, as was the
case in this patient. Finally, in this exciting era where the
elucidation of entire microbial genome sequences has become
possible, future studies correlating bacterial genomes and
proteomes with specific mechanisms of disease may hold
promise for identifying specific antigens involved in the
pathogenesis of immune-mediated conditions, such as shunt
nephritis.
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